Vitamin D and inflammatory bowel disease in children

Vitamin D supplementation in adolescents with inflammatory bowel disease: Does it work?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201712002835247

Enrollment

120

Registered

2017-12-04

Start date

2017-12-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Paediatrics IBD

Interventions

vitamin D supplementation

placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children with inflammatory bowel disease

Exclusion criteria

Exclusion criteria: children with recent use of antibiotics (4 weeks), normal vitamin D level, recent change in IBS therapy, history of gut surgery or radiation, chronic drug therapy, children with body mass index (BMI) of more than 25, chronic disease such as renal failure or diabetes mellitus, patients taking vitamin D supplementation

Design outcomes

Primary

Measure	Time frame
to assess IBD symptoms and severity score after treatment with vitamin D for 6 months.	—

Secondary

Measure	Time frame
correlation between serum vitamin D level and various clinical, radiological and laboratory variables	—

Countries

Egypt

Contacts

Public ContactNagat Elshmaa

assistant professor

nagat_elshmaa@yahoo.com201211865637

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026